Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation
활용도 Analysis
논문 Analysis
연구자 Analysis
'
Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation' 의 참고문헌
α(2)-adrenoceptors enhance cell proliferation and mammary tumor growth acting through both the stroma and the tumor cells
Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis
Therapeutics for advanced hepatocellular carcinoma : Recent advances, current dilemma, and future directions
The treatment of intermediate stage tumours beyond TACE : from surgery to systemic therapy
The role of cancer-associated fibroblasts and fibrosis in liver cancer
The antidepressant desipramine and alpha2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure
Stellate cells in tissue repair, inflammation, and cancer
Stellate cells and the development of liver cancer : therapeutic potential of targeting the stroma
Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model
Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase-3 activity
Roles for chemokines in liver disease
Reprogramming G protein coupled receptor structure and function
Propofol-induced miR-219-5p inhibits growth and invasion of hepatocellular carcinoma through suppression of GPC3-mediated Wnt/beta-catenin signalling activation
Propofol inhibits proliferation, migration, invasion and promotes apoptosis through down-regulating miR-374a in hepatocarcinoma cell lines
Propofol induces apoptosis of hepatocellular carcinoma cells by upregulation of microRNA-199a expression
Molecular signatures of G-protein-coupled receptors
Midazolam and dexmedetomidine affect neuroglioma and lung carcinoma cell biology in vitro and in vivo
Mechanisms of hepatic stellate cell activation
Local anesthetics inhibit the growth of human hepatocellular carcinoma cells
Involvement of alpha2-and beta2-adrenoceptors on breast cancer cell proliferation and tumour growth regulation
Innovative treatment for hepatocellular carcinoma(HCC)
Inflammatory cytokine tnfalpha promotes the long-term expansion of primary hepatocytes in 3D culture
In vivo effects of dexmedetomidine on immune function and tumor growth in rats with ovarian cancer through inhibiting the p38MAPK/NF-kappaB signaling pathway
Immunotherapy for hepatocellular carcinoma : recent advances and future perspectives
High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers
Hepatic stellate cells in liver development, regeneration, and cancer
Hepatic stellate cells as key target in liver fibrosis
Hepatic stellate cells : protean, multifunctional, and enigmatic cells of the liver
Hepatic stellate cell(vitamin A-storing cell)and its relative–past, present and future
Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma
Gut microbiota promotes obesity-associated liver cancer through PGE2-mediated suppression of antitumor immunity
Functional role of CCL5/RANTES for HCC progression during chronic liver disease
Early sedation with dexmedetomidine in critically Ill patients
Dexmedetomidine, an alpha 2a adrenergic receptor agonist, mitigates experimental autoimmune encephalomyelitis by desensitization of CXCR7 in microglia
Dexmedetomidine protects PC12 cells from lidocaine-induced cytotoxicity via downregulation of Stathmin 1
Dexmedetomidine promotes metastasis in rodent models of breast, lung, and colon cancers
Dexmedetomidine expands monocytic myeloid-derived suppressor cells and promotes tumour metastasis after lung cancer surgery
Alpha2-adrenoceptor agonists trigger prolactin signaling in breast cancer cells
Adrenergic receptor knockout mice : distinct functions of 9 receptor subtypes
'
Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation'
의 유사주제(
